MJSC yields 0.62% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, MJSC + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MJSC + JNJ for your $10,000?
MJSC invests in small-cap Japanese companies with pioneering business models, strong competitive positions, capable management, and attractive valuations. The portfolio includes common and preferred stocks, depositary receipts, REITs, IPOs, and ETFs. Stock selection follows a thematic process, combining quantitative screens and proprietary supply chain analysis to identify early-stage, high-growth companies positioned for structural and cyclical trends. The strategy seeks to capitalize on inefficiencies in Japan's under-researched small-cap market. While focused on Japan, the fund may allocate up to 20% of assets to companies outside Japan, including both emerging and developed markets. Up to one-third of the portfolio may be lent with collateral safeguards to generate additional income. Positions are actively monitored, with sales initiated when growth prospects weaken or valuations become stretched.
Full MJSC Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.